This study found that pediatric alopecia areata patients had significantly lower serum BDNF levels compared to healthy controls, which were associated with greater alopecia severity, higher depressive symptoms, and poorer quality of life.
In this study, trichoscopy was found to be a valuable non-invasive tool for diagnosing scalp lesions, enhancing diagnostic accuracy and reducing the need for scalp biopsies by identifying specific trichoscopic features associated with conditions like psoriasis, seborrheic dermatitis, and alopecia areata.
December 2024 in “International Journal on Science and Technology” In this study, researchers prepared a poly herbal hair oil using fresh plant leaves, including neem, and reported that these herbal formulations exhibit effective hair growth with fewer side effects compared to synthetic alternatives.
December 2024 in “Journal of Population Therapeutics and Clinical Pharmacology” This review highlights the potential benefits of using rosemary and kalonji seeds for hair health, focusing on their phytochemical properties, mechanisms of action, and therapeutic potential in treating conditions such as alopecia and dandruff.
October 2024 in “Journal of Education Health and Sport” This article reviews treatment options for Alopecia Areata, concluding that topical corticosteroids are effective for mild cases, while systemic therapies are advised for moderate to severe cases.
October 2024 in “La Tunisie Médicale” In this cross-sectional study conducted at Farhat Hached Hospital in Tunisia, more than half of the 60 alopecia areata patients surveyed experienced depression, particularly younger individuals and those with severe or specific forms of the condition, underscoring the need for psychological support.
July 2024 in “Medical alphabet” This study found that the SBN system effectively evaluates and describes the severity and clinical variant of alopecia areata using a standardized scale, aiding in patient management and disease course prediction.
April 2024 in “International Journal of Research Publication and Reviews” This source highlights that alopecia areata is a complex autoimmune disorder leading to patchy, nonscarring hair loss with variable treatment responses, reflecting unmet clinical needs. Advances in genetic research are improving understanding, yet current treatments often lead to persistent relapses.
January 2024 in “International Journal of Homoeopathic Sciences” In this case series, the researchers reported successful individualized homeopathic treatment for alopecia areata in three patients, with each case receiving a specific remedy—Natrum Muriaticum, Calcarea Carbonica, or Argentum Nitricum—resulting in positive treatment outcomes.
January 2024 in “International Journal of Dermatology Research” In this study, platelet-rich plasma therapy was observed to provide better improvement in hair regrowth for alopecia areata patients than intralesional triamcinolone acetonide, as measured by lower SALT scores.
December 2023 in “EPRA international journal of multidisciplinary research” In this review, researchers examined current knowledge on alopecia areata, finding it affects approximately 2% of individuals, with a likely autoimmune and genetic basis, and highlighting its association with other medical and psychiatric conditions, although no cure currently exists.
October 2023 in “Dermatology practical & conceptual” This study found that pulse corticosteroids effectively induce hair regrowth in alopecia areata, with betamethasone showing higher efficacy but more side effects, and treatment success varying depending on age, onset time, and disease type.
October 2023 in “European medical journal. Dermatology” This review outlines a systematic approach for dermatologists to accurately diagnose hair loss disorders, emphasizing the importance of differentiating between scarring and non-scarring alopecia to guide appropriate treatment decisions.
August 2023 in “International Ayurvedic medical journal” This case study describes the successful treatment of a 7-year-old girl with alopecia areata using Ayurvedic approaches targeting skin and autoimmune issues, suggesting a potential alternative to long-term oral corticosteroids, which can cause undesirable side effects.
This paper reviews the effectiveness and side effects of various treatments for androgenetic alopecia, telogen effluvium, and alopecia areata, emphasizing the importance of discussing each option's costs, benefits, and risks with patients.
June 2023 in “International journal of pharmaceutical quality assurance” This study found that videodermoscopy is a promising non-invasive tool for distinguishing between types of non-scarring alopecia on the scalp, highlighting its potential in dermatological practice.
June 2023 in “Dermatology and therapy” This study found that most dermatologists in the Middle East manage mild to severe alopecia areata primarily with potent topical corticosteroids and identified long-term disease control and improved efficacy as key unmet needs.
June 2023 in “Dermatology and therapy” This literature review highlights challenges in managing alopecia areata in the Middle East and Africa, noting significant regional gaps in data, treatment guidelines, and public awareness that impede patient care and emphasize the need for improved support and resources.
June 2023 in “Buletin de psihiatrie integrativă” This research highlights that alopecia, while not physically harmful, significantly impacts individuals' mental health due to its effects on self-image, and suggests a management strategy that includes psychological counseling alongside dermatological treatment to address these challenges.
August 2022 in “Revista de la Universidad Industrial de Santander/Salud UIS” This case report details a 37-year-old woman with alopecia areata who experienced significant hair regrowth after psychological stress-triggered hair loss, following treatment with topical corticosteroids and tofacitinib.
January 2022 in “Al-Azhar Medical Journal” This study found a significant association between antigliadin antibodies (IgA and IgG) and alopecia areata severity, suggesting a need for celiac disease screening in these patients.
January 2021 in “Online Publication Service of Würzburg University (Würzburg University)” This study examines the use of diphenylcyclopropenone in treating alopecia areata patients at the University Hospital Würzburg and investigates how the treatment affects patients' quality of life.
This article reviews common disorders leading to hair loss in females and discusses their clinical features and management strategies, but it presents no new clinical results.
October 2018 in “Springer eBooks” The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.
June 2018 in “The Medical Journal of Cairo University/The Medical Journal of Cairo University” This study found that dermoscopy is effective for distinguishing Tinea Capitis from Alopecia Areata by identifying unique trichoscopic features specific to each condition.
May 2017 in “Journal of The American Academy of Dermatology” This study found an increase in allergic contact dermatitis cases linked to natural products like propolis and marigold, predominantly affecting women in a Bulgarian population.
May 2017 in “Journal of The American Academy of Dermatology” This study reported an increase in allergic contact dermatitis cases linked to natural products, particularly propolis and marigold, with a higher incidence in women than men.
January 2017 in “Springer eBooks” The document explains various skin conditions and their treatments.
December 2016 in “John Wiley & Sons, Ltd eBooks” This chapter reviews disorders of skin appendages including miliaria, acne, and alopecia, providing guidance on management and treatment but does not present new clinical findings.
In this study, researchers found that alopecia areata is linked to immune cell activation against hair follicle autoantigens and is associated with heart changes and cardiac marker alterations in humans and mice.